300534 Stock Overview
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD investiga, desarrolla, produce y vende medicamentos chinos patentados, alimentos saludables y API en China y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.47 |
| 52 Week High | CN¥12.36 |
| 52 Week Low | CN¥6.30 |
| Beta | 0.51 |
| 1 Month Change | 2.42% |
| 3 Month Change | -16.06% |
| 1 Year Change | -13.31% |
| 3 Year Change | 53.72% |
| 5 Year Change | 11.74% |
| Change since IPO | 50.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300534 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.5% | 0.8% | 1.7% |
| 1Y | -13.3% | -13.0% | -15.8% |
Rentabilidad frente al sector: 300534 igualó al sector CN Pharmaceuticals , que obtuvo un rendimiento del -12.2% el año pasado.
Rentabilidad vs. Mercado: 300534 superó al mercado CN, que obtuvo un rendimiento del -20.5% el año pasado.
Price Volatility
| 300534 volatility | |
|---|---|
| 300534 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 11.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 300534ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 300534 (9%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 320 | Shuangxi Qian | https://www.lsrfzy.com |
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD investiga, desarrolla, produce y vende medicamentos chinos patentados, alimentos saludables y API en China y a escala internacional. La empresa ofrece la mezcla Xuanfei Zhicough, las píldoras cuentagotas Yuanhu Zhitong, las cápsulas Qiwei Wenyang, la cápsula Maxing para la tos y las cápsulas Astragalus Angelica. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD se fundó en 2002 y tiene su sede en Lanzhou, China.
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Fundamentals Summary
| 300534 fundamental statistics | |
|---|---|
| Market cap | CN¥2.57b |
| Earnings (TTM) | CN¥56.63m |
| Revenue (TTM) | CN¥824.45m |
45.4x
P/E Ratio3.1x
P/S RatioIs 300534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300534 income statement (TTM) | |
|---|---|
| Revenue | CN¥824.45m |
| Cost of Revenue | CN¥335.25m |
| Gross Profit | CN¥489.20m |
| Other Expenses | CN¥432.57m |
| Earnings | CN¥56.63m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 24, 2024
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 59.34% |
| Net Profit Margin | 6.87% |
| Debt/Equity Ratio | 20.5% |
How did 300534 perform over the long term?
See historical performance and comparison